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Summary
Congenital dyserythropoietic anemias (CDA) are a rare
group of red-blood-cell disorders of unknown etiology
that are characterized by ineffective erythropoiesis, pa-
thognomonic cytopathology of the nucleated red blood
cells in the bone marrow, and secondary hemochro-
matosis. In CDA type I, bone-marrow electron micros-
copy reveals characteristic findings in erythroid precur-
sors, including spongy heterochromatin and enlarged
nuclear pores. Since the genetic basis of CDA type I is
not evident, we used homozygosity and linkagemapping
to localize the genetic defect responsible for CDA type
I in 25 Bedouins from four large consanguineous fam-
ilies. We report the linkage of this disease to markers on
chromosome 15 located at q15.1-q15.3. Fourteen mark-
ers within a 12-cM interval were typed in the relevant
family members. Nine of the markers yielded maximum
LOD scores of 1.625–12.928 at a recombination frac-
tion of .00. Linkage disequilibrium was found only with
marker D15S779. Haplotype analysis revealed eight dif-
ferent carrier haplotypes and highlighted the existence
of a founder haplotype. Identification of historical cross-
over events further narrowed the gene location to be-
tween D15S779 and D15S778. The data suggest local-
ization of the CDA type I gene within a 0.5-cM interval.
The founder mutation probably occurred x400 years
ago. Sequence analysis of the coding region of protein
4.2, the only known erythroid-specific gene in the locus,
did not reveal any change in the CDA type I patients.
Future analysis of this locus may lead to the identifi-
cation of a gene essential to normal erythropoiesis.
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Introduction
Congenital dyserythropoietic anemias (CDA) are a rare
group of red-blood-cell disorders of unknown etiology
that are characterized by ineffective erythropoiesis, pa-
thognomonic cytopathology of the nucleated red blood
cells in the bone marrow, and secondary hemochro-
matosis. In 1968, Heimpel and Wendt classified these
disorders into three types, which were later confirmed
by electron microscopy and serological findings (Alter
and Young 1993). Type I (MIM 224120) is associated
with moderate congenital macrocytic anemia, megalo-
blastoid erythroid hyperplasia, and the presence of nu-
clear-chromatin bridges between erythroblasts. Bone-
marrow electron microscopy reveals characteristic find-
ings in erythroid precursors, including spongy hetero-
chromatin, enlargement of the nuclear pores, and oc-
casional invagination of cytoplasmic organelles into the
nuclear area. The underlying mechanisms for those ab-
normalities are unknown. We recently demonstrated
that, in CDA type I, the ultrastructural morphological
features of the erythroid precursors resemble apoptosis,
and S-phase arrest is also found (Tamary et al. 1996).
More than 70 sporadic cases of CDA type I have been
reported (Wickramasinghe 1997). We recently described
a cluster of 20 Israeli Bedouin patients with the disease
(Tamary et al. 1996). The pattern of inheritance is au-
tosomal recessive (Heimpel and Wendt 1968). We
showed that 55% of the patients manifested at the neo-
natal period with anemia and jaundice and that 88% of
those neonates required blood transfusions during the
1st mo of life (Shalev et al. 1997). Few patients display
patches of brown skin pigmentation and congenital skel-
etal abnormalities (Wickramasinghe 1997). Later in life,
jaundice, splenomegaly, and moderate macrocytic ane-
mia are usually present. The condition is compatible
with normal survival but carries an increased risk of
gallstone development, iron overload, and secondary he-
mochromatosis. Only a few patients are more severely
affected and are transfusion dependent (Heimpel 1998).
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The more common CDA type II, also known as “he-
reditary erythroblastic multinuclearity with a positive
acidified serum” (HEMPAS) test (Lewis and Frisch
1973), is an autosomal recessive disorder manifested by
normocytic anemia, variable jaundice, and hepatosplen-
omegaly. Bone-marrow aspiration disclosed bi- and mul-
tinucleated erythroblasts and karyorrhexis. Biochemical
data suggested that this disease is due to a deficiency of
either N-acetylglucoaminyltransferase II or a-mannosi-
dase II (Fukuda et al. 1992). However, recent linkage
analysis has excluded, as candidate genes, those genes
encoding these proteins, and the CDA type II gene has
been mapped to chromosome 20 (20q11.2) (Gasparini
et al. 1997; Iolascon et al. 1997).
CDA type III is associated with anemia, jaundice, and
occasional splenomegaly and is identified by the presence
of macrocytosis and bone-marrow erythroblastic mul-
tinuclearity with prominent gigantoblasts (Alter and
Young 1993). The pattern of inheritance is autosomal
dominant. The defect in CDA type III was recently lo-
calized to chromosome 15q21-q22 (Lind et al. 1995).
The autosomal recessive inheritance of CDA type I
and the consanguineous nature of the Bedouin families
make these families suitable candidates for homozygos-
ity mapping (Lander and Botstein 1987). In the present
study, we used homozygosity linkage mapping to localize
the genetic defect responsible for CDA type I in four
consanguineous Bedouin families. We demonstrate the
close linkage of CDA type I to microsatellite markers
on chromosome 15 (15q15.1-15.3). Moreover, the car-
rier chromosome haplotype revealed the existence of an
ancestor haplotype and a possible major mutation in the
Bedouin population. The age of the mutation has been
estimated.
Families and Methods
Families
The 25 CDA type I patients investigated (most of
whom have been described elsewhere [Tamary et al.
1996]) are part of four large consanguineous Bedouin
families (fig. 1). Diagnosis was confirmed by typical
bone-marrow–erythroid electron-microscopy findings,
in all cases.
DNA Extraction
Blood samples were obtained from the 25 affected
patients and from 45 other family members (fig. 1). DNA
was prepared from peripheral blood leukocytes as de-
scribed elsewhere (Poncz et al. 1982). All subjects gave
their informed consent.
Genotype Analysis
Primer pairs for the detection of 157 polymorphic
markers were obtained from Research Genetics (Human
Screening Panel, version 5a). These markers consist of
highly polymorphic short tandem repeats (STRs), mostly
tri- and tetranucleotide repeats, developed by the Co-
operative Human Linkage Center. The average hetero-
zygosity of those markers is .8.
PCR amplification was performed in a final volume
of 15 ml containing 45 ng of purified genomic DNA, 10
mM Tris-HCl pH 8, 1.5 mM MgCl2, 50 mM KCl,
0.01% gelatin, 200 mM of each dNTP, 0.25 U of Taq
polymerase (Perkin Elmer Cetus), and 3 pmol of each
primer. Amplification was performed for 34 cycles,
each with denaturation at 94C for 30 s, annealing at
54C–59C for 1 min, and extension at 72C for 1 min,
followed by final extension at 72C for 5 min. The am-
plified products were separated by electrophoresis on a
5%–15% denaturating polyacrylamide gel. Allele sizes
were determined by comparison with MspI-digested
pBR322, which was included as a size standard in the
gels. All markers were scored independently by two ob-
servers; the scores were compared, and any discrepancies
were resolved by reexamination of the gels.
In an attempt to pinpoint the CDA type I gene lo-
cation, additional STR markers (Allamand et al. 1995;
Chainnilkulchai et al. 1995; Richard et al. 1995) map-
ping to the region of interest (15q15.1-15.3) were used.
Their primer sequences were obtained from the Genome
Database via URL http://gdbwww.gdb.org/. DNA sam-
ples from all affected individuals and their family mem-
bers were typed for the additional markers.
Statistical Analysis
LOD scores between the gene for CDA type I and the
various markers were calculated with the LIPED pro-
gram, version 5.0 (Ott 1974). An autosomal recessive
model with complete penetrance in both sexes, a fre-
quency of .005 for the disease allele, and equal allele
frequencies for each marker were assumed. The relevant
family members were fully typed for all loci, making the
results insensitive to allele frequencies. Specific allele fre-
quencies in our population were also estimated by cal-
culation of their frequency of occurrence in the noncar-
rier chromosome.
The linkage disequilibrium of each microsatellite with
the CDA type I locus was examined by comparison of
marker-allele frequencies in CDA type I chromosomes
versus marker-allele frequencies in normal chromo-
somes, by x2 test with the contingency table,2# K
where K is the number of unique marker alleles present
in the sample. The significance of the association was
determined by a right-sided x2 test with df.K 1
The maximum-likelihood technique was applied to
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Figure 1 Pedigree of four CDA type I Bedouin families. Affected family members are denoted by blackened symbols; males are denoted
by squares; and females are denoted by circles. The most likely haplotype for the chromosome 15 markers is shown below each family member
for whom DNA was available. The order of the markers, from the top to the bottom of each bar, is D15S129, D15S779, D155S778, D15S222,
D15S659, D15S132, and D15S161. Carrier haplotypes are denoted by asterisks (*); and noninformative regions are denoted by gray shading.
estimate the number of generations, g, that have elapsed
since the origin of a given haplotype from one common
chromosome (Bonne-Tamir and Korostishevsky 1997).
The length of the common segments flanking the pu-
tative mutation site was measured for each haplotype
pair among the 15 unrelated obligate-carrier haplotypes
identified in the population. The basic assumptions were
that the haplotypes are derived from the same mutant
chromosome and that the length of the intact interval
is limited by recombination events only. The support
interval for g was based on a 1-LOD-unit support in-
terval for each of the recombinations (Risch et al. 1995).
Automated DNA Sequence Analysis
The genomic organization of the protein 4.2 gene has
been reported elsewhere (Korsgren and Cohen 1991).
Amplified functional regions of the gene (promoter and
exons, including exon-intron borders) were sequenced
by fluorescence-based DNA sequence analysis, by use of
a Taq Dye Terminator Cycle Sequencing Kit on a Prism
377 DNA sequencer (Applied Biosystems).
Results
Linkage Analysis
A genomewide search for regions of homozygosity by
descent, by means of STR markers, was conducted with
use of DNA from 25 Bedouins affected with CDA type
I. The first marker exhibiting homozygosity was located
on chromosome 15q (D15S659) and was found in 14
individuals. Genotyping of 45 unaffected individuals
representing the parents and siblings of the affected in-
dividuals in the four families revealed only 4 individuals
who were homozygous for this marker.
An additional 13 markers were then examined; the
maximum LOD score (12.928) was later obtained with
D15S778. Linkage of adjacent markers confirmed lo-
calization of the CDA type I gene to region
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Table 1
Pairwise LOD Scores between Chromosome 15 Markers and the CDA Type I Locus
MARKER
LOD SCORE AT RECOMBINATION FRACTION OF
MAXIMUM
LOD
SCORE
ESTIMATED RE-
COMBINATION
FRACTION.000 .001 .050 .100 .200 .03 .04
D15S129  3.271 5.181 4.787 3.247 1.907 .586 5.190 .04
D15S1044  1.725 3.943 3.688 8.626 1.450 .456 3.943 .05
D15S514 9.718 9.695 8.533 7.351 5.044 2.909 1.094 9.718 .00
D15S779 11.815 11.837 11.135 9.842 7.004 4.166 1.632 11.837 .00
D15S780 8.237 8.218 7.287 6.325 4.402 2.572 1.001 8.237 .00
D15S515 1.625 1.620 1.349 1.096 .665 .344 .127 1.625 .00
D15S778 12.928 12.900 11.533 10.108 7.211 4.358 1.776 12.928 .00
D15S784 10.901 10.876 9.617 8.318 5.724 3.259 1.184 10.901 .00
D15S783 10.284 10.261 9.131 7.982 5.664 3.411 1.345 10.284 .00
D15S781 5.881 5.815 5.046 4.271 2.768 1.406 .387 5.831 .00
D15S222 6.393 6.381 5.728 5.017 3.509 1.985 .650 6.393 .00
D15S659  4.860 5.585 4.903 3.313 1.772 .525 5.783 .02
D15S132  1.262 5.325 5.155 3.878 2.255 .740 5.350 .06
D15S161  1.220 2.350 2.442 1.840 1.035 .319 2.47 .08
Figure 2 All informative recombinations between the gene for
CDA type I and genetic markers on chromosome 15. The microsatellite
map was inferred from the study by Allamand et al. (1995) and the
present study (table 2). Portions of chromosomal regions containing
the gene for CDA type I are denoted by hatching; vertical lines denote
noninformative regions; and bars without hatching denote regions that
do not include the gene.
D15S514–D15S222 on the proximal part of 15q15.1-
15.3 (table 1). The order and distance of additional
flanking markers were calculated by marker-to-marker
linkage analysis (data not shown).
All informative recombinations are presented in figure
2. Two key recombinant events were observed, one in
family A (member A-6) and the other in family C (mem-
ber C-12). In A-6, recombination had occurred between
the gene for CDA and D15S659, localizing the gene as
telomeric to D15S222. Recombination in C-12 localized
the gene as centromeric to D15S1044. The integrated
data from all the recombination events showed that the
candidate region lies between markers D15S659 and
D15S1044.
Linkage Disequilibrium
At total of 26 different haplotypes were evaluated,
including 18 “normal” chromosomes and 8 carrier chro-
mosomes (table 2). Chromosomes either shared by two
siblings or from a common consanguineous origin were
counted only once. Allelic association between the CDA
type I gene and each of the markers, as determined by
x2 test, revealed a marked association with the D15S779
marker ( , ; see table 3). Allele 5 in2x  20.25 P  .005
marker D15S779 was observed in 7 of 8 different carrier
haplotypes and in 0 of 18 non-carrier haplotypes. No
other marker showed any significant association.
Haplotype Analysis
The haplotypes of the affected individuals and their
available parents and siblings were then analyzed to
identify informative historical crossover events that
would permit finer localization of the gene for CDA type
I (fig. 1). Eight different carrier haplotypes were con-
structed, by use of 14 markers, for affected family mem-
bers (table 2). A comparison between the carrier hap-
lotypes revealed the existence of historical recombinant
events and narrowed the CDA type I location to between
D15S779 and D15S778, as the common interval for all
the carrier haplotypes (table 2). Allele 4 in marker
D15S781 and allele 2 in marker D15S515 were common
to all the haplotypes. However, since allele changes can
result from mutations, particularly when only a single
variant allele is buried in the middle of a conserved hap-
Table 2
Eight Carrier Haplotypes Segregating within the Families with CDA Type I
HAPLOTYPE
ALLELE AT LOCUSa
FAMILIESbD15S129 D15S1044 D15S514 D15S779 D15S780 D15S515 D15S778 D15S784 D15S783 D15S781 D15S222 D15S659 D15S132 D15S161
I 6 3 1 5 4 2 5 4 1 4 8 4 5 6 B (3), C (3), D (2)
II 6 3 1 5 4 2 5 4 4 4 6 3 1 3 D (1)
III 6 3 1 5 4 2 4 5 2 4 4 4 2 5 B (1)
IV 4 1 1 5 4 2 5 4 1 4 8 4 5 5 D (1)
V 7 2 1 5 4 2 5 4 1 4 8 3 5 1 A (1)
VI 7 2 1 5 4 2 5 4 1 4 4 3 5 1 C (1), D (1)
VII 3 3 1 6 4 2 5 4 1 4 4 3 5 1 C (1)
VIII 6 3 1 5 4 2 5 4 1 4 8 4 5 5 A (1)
a Data within the “frame” are identical to the common haplotype.
b Numbers in parentheses are number of unrelated haplotypes in same family.
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Table 3
Allelic Association between the CDA Type I Gene
and Markers on Chromosome 15q15
Locus x2 a df P Heterozygosityb
D15S129 8.34 5 .141 .77
D15S1044 7.00 4 .135 .64
D15S514 6.62 4 .159 .63
D15S779 2.25 7 .005 .82
D15S780 5.54 4 .237 .67
D15S515 1.26 1 .262 .23
D15S778 6.32 4 .196 .73
D15S784 5.37 5 .393 .69
D15S783 3.76 2 .153 .55
D15S781 7.84 4 .097 .64
D15S222 4.89 5 .429 .75
D15S659 6.91 5 .228 .77
D15S132 11.2 5 .048 .76
D15S161 1.48 5 .915 .75
a Between 8 different carrier haplotypes and 18 dif-
ferent noncarrier parental haplotypes.
b Based on allele frequencies in 18 different non-
carrier parental haplotypes.
lotype (e.g., allele 6 in marker D15S779 and allele 4 in
marker D15S778; see table 2), the actual interval can
be between D15S514 and D15S784.
A total of 16 unrelated obligate carrier haplotypes
were identified in the families studied. Two groups of
haplotypes sharing either all the alleles or all except one
allele were identified. The first group of haplotypes,
evenly distributed in all the families, contains eight of
haplotype I and one of haplotype VIII. The second group
of haplotypes contains one of haplotype V and two of
haplotype VI. The common region between these two
groups of haplotypes includes an interval of ∼7 cM be-
tween D15S1044 and D15S222, which is preserved in
13 (81%) of the 16 obligate-carrier haplotypes.
Another four haplotypes were found in a single copy
each: haplotypes II and IV in family D, haplotype III in
family B, and haplotype V in family A. Haplotypes II–IV
most likely resulted from a single recombinant event in-
volving a haplotype of the first group, whereas haplotype
VII is the result of a single recombination event in the
second group.
According to our calculation, we estimate g as being
32.18 (range 17.68–49.74), with the support interval
based on 1 LOD unit (Risch et al. 1995).
Sequence Analysis of the Protein 4.2 Gene
No change in the sequence of the protein 4.2 gene
(Korsgren and Cohen 1991) was detected by automatic
sequencing of the amplified promotor region (385 bp
upstream of the initiation codon), exons, and exon-in-
tron borders (exons 1–13) in the four patients we
examined.
Discussion
CDA type I is a rare autosomal recessive disease char-
acterized by moderate macrocytic anemia with typical
electron-microscopy findings in erythroid precursors, in-
cluding spongy heterochromatin and enlargement of
nuclear pores (Lewis and Frisch 1973). Although most
patients suffer from moderate anemia, a few are more
severely affected and are transfusion dependent. In a
previous report, we have suggested that the erythroid
bone-marrow electron-microscopy findings resemble
apoptosis, whereas the S-phase arrest, also described in
those precursors, may be secondary to the observed
apoptosis (Tamary et al. 1996). The basic defect in this
disease remains unknown.
The gene for CDA type II recently has been localized
to chromosome 20q11.2 (Iolascon et al. 1997), and the
gene for CDA type III has been localized to chromosome
15q21-15q22 (Lind et al. 1995). Our patients, however,
revealed no linkage to those markers.
Homozygosity-mapping analysis in Israeli Bedouins
with CDA type I suggests that the gene for CDA type I
is localized to an ∼7-cM area on chromosome 15q15.1-
15.3. Additional genetic information was obtained by
linkage-disequilibrium and haplotype analysis. Although
linkage disequilibrium alone may be misleading if data
are derived from a single population (Allamand and
Beckmann 1997), the combined strategy allowed us to
localize our gene to an interval of ∼ 0.5 cM between
markers D15S779 and D15S778, corresponding in this
region to 1.3–1.6 Mb (Chiannilkulchai et al. 1995).
However, if microsatellite divergence is due to mutation,
the interval many be longer—that is, between D15S514
and D15S784. The CDA type I locus is ∼20 cM cen-
tromeric to the locus for CDA type III.
While searching for the gene for the recessive form of
limb-girdle muscular dystrophy 2A, Chiannilkulchai et
al. (1995) generated a primary-muscle–expression map
of chromosome 15q15 and revealed 17 sequences cor-
responding to 5 known genes and 12 new ones. In a
previous report, erythrocyte membrane protein 4.2
(EPB4.2) has been localized to 15q15 (Najfeld et al.
1992). EPB4.2 is a membrane protein that helps to bind
the red-blood-cell cytoskeleton to the lipid bilayer, prob-
ably by anchoring it to ankaryin. EPB4.2 deficiency is
associated with congenital spherocytosis (Gallagher et
al. 1998). Therefore, it was not considered, a priori, to
be a candidate gene for CDA type I. However, since
EPB4.2 is the only erythroid-specific gene in the CDA
type I interval, we consider it a candidate, assuming that
this protein has some unknown properties. However,
sequence analysis of functionally important regions in
the EPB4.2 gene did not disclose any changes in se-
quence, thus decreasing the likelihood of involvement of
EPB4.2 in CDA type I.
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Close examination of the eight carrier haplotypes
found among our CDA type I patients suggests that all
of the haplotypes share at least two markers, D15S515
and D15S780, whereas 81% of them share a larger,
7-cM, ancestor haplotype, D15S2044–D15S659, with
possible recombinations in the flanking regions (table
2). These data point to a single founder mutation for
most of the carrier haplotypes that we studied.
The Bedouins living in Israel originated mainly in the
Arabian peninsula; the few members who were not orig-
inally nomads joined them at a later stage (Marx 1967,
pp. 3–31). Our patients are members of what seem to
be four unrelated families. However, no written history
is available, and there is no objective way of determining
their exact ethnic origin. On the basis of our data, all
four consanguineous families apparently stem from a
common ancestor estimated to have lived ∼400–500
years ago.
The data provided here may serve as the starting point
for identification of the gene responsible for CDA type
I. They should also provide further insight into normal
and abnormal erythroid differentiation.
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